JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$1.18B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.07B |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$963M |
| 5 |
Medtronic
MDT
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.5B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$716M |
| 4 |
Chubb
CB
|
+$675M |
| 5 |
Lowe's Companies
LOW
|
+$661M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.77% |
| 2 | Technology | 12.5% |
| 3 | Healthcare | 9.29% |
| 4 | Consumer Discretionary | 8.66% |
| 5 | Industrials | 8.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Fate Therapeutics
FATE
$294M
| $4.17M | ﹤0.01% |
427,420
+398,372
| +1,371% | +$3.82M |
|
|
UBA
2602
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $4.17M | ﹤0.01% |
215,961
-74,799
| -26% | -$1.43M |
|
|
PPBI
2603
DELISTED
Pacific Premier Bancorp
PPBI
| $4.17M | ﹤0.01% |
103,586
+1,213
| +1% | +$50.5K |
|
2604
PUT
Truist Financial
TFC
$64.7B
| $4.16M | ﹤0.01% |
80,000
-210,900
| -72% | -$11.4M |
|
|
EGOV
2605
DELISTED
NIC Inc
EGOV
| $4.16M | ﹤0.01% |
312,764
-82,217
| -21% | -$1.22M |
|
|
NEE.PRQ
2606
DELISTED
NextEra Energy, Inc.
NEE.PRQ
| $4.16M | ﹤0.01% |
57,000
-42,940
| -43% | -$2.96M |
|
|
GSV
2607
DELISTED
Gold Standard Ventures Corp.
GSV
| $4.16M | ﹤0.01% |
+2,549,440
| New | +$4.31M |
|
2608
Matthews International
MATW
$722M
| $4.15M | ﹤0.01% |
82,090
-11,480
| -12% | -$609K |
|
2609
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$12B
| $4.14M | ﹤0.01% |
133,144
-193,996
| -59% | -$6.22M |
|
2610
Ardelyx
ARDX
$1.01B
| $4.13M | ﹤0.01% |
817,567
+57,086
| +8% | +$356K |
|
2611
CALL
Tenet Healthcare
THC
$21.5B
| $4.12M | ﹤0.01% |
+170,000
| New | +$3.38M |
|
|
WP
2612
CALL
DELISTED
Worldpay, Inc.
WP
| $4.11M | ﹤0.01% |
+50,000
| New | +$3.97M |
|
2613
Silicon Laboratories
SLAB
$7.28B
| $4.1M | ﹤0.01% |
45,629
-67,103
| -60% | -$6.33M |
|
2614
PUT
AT&T
T
$168B
| $4.1M | ﹤0.01% |
152,260
-1,725,702
| -92% | -$48M |
|
2615
Madrigal Pharmaceuticals
MDGL
$11.7B
| $4.09M | ﹤0.01% |
35,051
+34,055
| +3,419% | +$4.2M |
|
|
LJPC
2616
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $4.08M | ﹤0.01% |
137,144
+133,372
| +3,536% | +$4.3M |
|
|
SPN
2617
DELISTED
Superior Energy Services, Inc.
SPN
| $4.06M | ﹤0.01% |
48,210
-35,100
| -42% | -$3.46M |
|
2618
Uranium Energy
UEC
$5.54B
| $4.06M | ﹤0.01% |
3,100,992
+306,634
| +11% | +$455K |
|
2619
CALL
BioMarin Pharmaceuticals
BMRN
$13.3B
| $4.05M | ﹤0.01% |
50,000
| – | – |
|
|
2620
PUT
BioMarin Pharmaceuticals
BMRN
$13.3B
| $4.05M | ﹤0.01% |
50,000
| – | – |
|
|
GWR
2621
DELISTED
Genesee & Wyoming Inc.
GWR
| $4.05M | ﹤0.01% |
57,254
+20,043
| +54% | +$1.51M |
|
2622
United Fire Group
UFCS
$1.38B
| $4.05M | ﹤0.01% |
84,626
-11,634
| -12% | -$524K |
|
|
TVRD
2623
Tvardi Therapeutics
TVRD
$22.1M
| $4.04M | ﹤0.01% |
9,074
-783
| -8% | -$380K |
|
|
CNR
2624
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $4.02M | ﹤0.01% |
227,237
+4,485
| +2% | +$79.1K |
|
2625
CoStar Group
CSGP
$13.4B
| $4.01M | ﹤0.01% |
110,700
+230
| +0.2% | +$7.93K |
|
Similar funds
JP Morgan Chase's Q1 2018 Portfolio in Review
As of Q1 2018, JP Morgan Chase held 5,855 positions worth $467B, down 1.7% from $475B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2018 filing shows 386 new, 1,953 increased, 2,570 reduced and 469 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M. The largest sale was Apple, an estimated $1.5B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M.
- JP Morgan Chase added most to iShares MSCI Japan ETF in Q1 2018, an estimated $1.18B increase.
- JP Morgan Chase's biggest Q1 2018 reduction was Apple, cutting an estimated $1.5B.
- JP Morgan Chase fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $168M.
- JP Morgan Chase's ten largest holdings make up 18% of its $467B portfolio in Q1 2018.
- JP Morgan Chase opened 386 new positions and closed 469 in Q1 2018.
- JP Morgan Chase's portfolio value fell 1.7% quarter-over-quarter to $467B.
Based on JP Morgan Chase's 13F filing for Q1 2018, filed 10 May 2018.